Is Pot Stock Trulieve Cannabis a Buy in 2020?
At this time last year, cannabis stocks appeared primed to push toward profitability. To our north, Canada had recently legalized adult-use weed sales, while higher-margin derivatives were set to hit dispensary shelves in the latter half of 2019. Meanwhile, a number of U.S. states were considering the legalization of recreational or medical cannabis. It looked like the perfect setup, but looks can sometimes be deceiving.
Following an incredible first quarter, most pot stocks spent the rest of 2019 in a precipitous downtrend. However, vertically integrated multistate operator (MSO) Trulieve Cannabis (OTC: TCNNF) was an exception to the rule. Trulieve's 47% gain in 2019 wound up handily outpacing the 29% return of the benchmark S&P 500.
The big question is, can this outperformance continue in 2020?
Source Fool.com
